These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18460212)

  • 1. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.
    Schoepflin S; Marfurt J; Goroti M; Baisor M; Mueller I; Felger I
    Malar J; 2008 May; 7():78. PubMed ID: 18460212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013.
    Hawkes M; Conroy AL; Opoka RO; Namasopo S; Zhong K; Liles WC; John CC; Kain KC
    Emerg Infect Dis; 2015 Jul; 21(7):1237-9. PubMed ID: 26079933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Antimalarial Drug Resistance Markers in the Reservoir of Plasmodium falciparum Infections in the Upper East Region of Ghana.
    Narh CA; Ghansah A; Duffy MF; Ruybal-Pesántez S; Onwona CO; Oduro AR; Koram KA; Day KP; Tiedje KE
    J Infect Dis; 2020 Oct; 222(10):1692-1701. PubMed ID: 32459360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
    Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.
    Oladipo OO; Wellington OA; Sutherland CJ
    Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
    Osorio L; Gonzalez I; Olliaro P; Taylor WR
    Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
    Guerra M; Neres R; Salgueiro P; Mendes C; Ndong-Mabale N; Berzosa P; de Sousa B; Arez AP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major subpopulations of
    Amambua-Ngwa A; Amenga-Etego L; Kamau E; Amato R; Ghansah A; Golassa L; Randrianarivelojosia M; Ishengoma D; Apinjoh T; Maïga-Ascofaré O; Andagalu B; Yavo W; Bouyou-Akotet M; Kolapo O; Mane K; Worwui A; Jeffries D; Simpson V; D'Alessandro U; Kwiatkowski D; Djimde AA
    Science; 2019 Aug; 365(6455):813-816. PubMed ID: 31439796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016).
    Prosser C; Meyer W; Ellis J; Lee R
    PLoS One; 2018; 13(5):e0197369. PubMed ID: 29813085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates.
    Nagesha HS; Casey GJ; Rieckmann KH; Fryauff DJ; Laksana BS; Reeder JC; Maguire JD; Baird JK
    Am J Trop Med Hyg; 2003 Apr; 68(4):398-402. PubMed ID: 12875286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.